James Fagin
James Fagin
Unknown affiliation
Verified email at
Cited by
Cited by
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ...
Cell 159 (3), 676-690, 2014
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
ET Kimura, MN Nikiforova, Z Zhu, JA Knauf, YE Nikiforov, JA Fagin
Cancer research 63 (7), 1454-1457, 2003
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial
SA Wells Jr, BG Robinson, RF Gagel, H Dralle, JA Fagin, M Santoro, ...
Journal of clinical oncology 30 (2), 134, 2012
BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas
MN Nikiforova, ET Kimura, M Gandhi, PW Biddinger, JA Knauf, F Basolo, ...
The Journal of Clinical Endocrinology & Metabolism 88 (11), 5399-5404, 2003
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ...
The Journal of clinical investigation 126 (3), 1052-1066, 2016
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer
M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei, B Bendlova, L Yip, ...
Jama 309 (14), 1493-1501, 2013
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify …
RM Tuttle, H Tala, J Shah, R Leboeuf, R Ghossein, M Gonen, M Brokhin, ...
Thyroid 20 (12), 1341-1349, 2010
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
AL Ho, RK Grewal, R Leboeuf, EJ Sherman, DG Pfister, D Deandreis, ...
New England Journal of Medicine 368 (7), 623-632, 2013
Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules
YE Nikiforov, DL Steward, TM Robinson-Smith, BR Haugen, JP Klopper, ...
The Journal of Clinical Endocrinology & Metabolism 94 (6), 2092-2098, 2009
Distinct Pattern of ret Oncogene Rearrangements in Morphological Variants of Radiation-induced and Sporadic Thyroid Papillary Carcinomas in Children
YE Nikiforov, JM Rowland, KE Bove, H Monforte-Munoz, JA Fagin
Cancer Research 57 (9), 1690-1694, 1997
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
JA Fagin, K Matsuo, A Karmakar, DL Chen, SH Tang, HP Koeffler
The Journal of clinical investigation 91 (1), 179-184, 1993
Biologic and clinical perspectives on thyroid cancer
JA Fagin, SA Wells Jr
New England Journal of Medicine 375 (11), 1054-1067, 2016
A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies
JS Forrester, M Fishbein, R Helfant, J Fagin
Journal of the American College of Cardiology 17 (3), 758-769, 1991
Clonal origin of pituitary adenomas
The Journal of Clinical Endocrinology & Metabolism 71 (6), 1427-1433, 1990
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1
JC Ricarte-Filho, M Ryder, DA Chitale, M Rivera, A Heguy, M Ladanyi, ...
Cancer research 69 (11), 4885-4893, 2009
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification
RE Schweppe, JP Klopper, C Korch, U Pugazhenthi, M Benezra, ...
The Journal of Clinical Endocrinology & Metabolism 93 (11), 4331-4341, 2008
Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas
P Lito, CA Pratilas, EW Joseph, M Tadi, E Halilovic, M Zubrowski, ...
Cancer cell 22 (5), 668-682, 2012
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer
M Xing, AS Alzahrani, KA Carson, YK Shong, TY Kim, D Viola, R Elisei, ...
Journal of clinical oncology 33 (1), 42, 2015
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
R Ciampi, JA Knauf, R Kerler, M Gandhi, Z Zhu, MN Nikiforova, HM Rabes, ...
The Journal of clinical investigation 115 (1), 94-101, 2005
Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells
MN Nikiforova, JR Stringer, R Blough, M Medvedovic, JA Fagin, ...
Science 290 (5489), 138-141, 2000
The system can't perform the operation now. Try again later.
Articles 1–20